Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 01:45 ET | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
October 30, 2025 09:09 ET | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
October 27, 2025 10:15 ET | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) DEADLINE ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
October 20, 2025 11:20 ET | Source: Berger Montague

Berger Montague PC Investigating Claims on Behalf of MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors After Class Action Filing

PHILADELPHIA, Oct. 20, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or...
October 20, 2025 08:30 ET | Source: Bernstein Liebhard LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
October 16, 2025 16:03 ET | Source: Bernstein Liebhard LLP

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) INVESTOR ALERT Investors With Large Losses in MoonLake Immunotherapeutics Should Contact Bernstein Liebhard LLP To Discuss Their Rights

MoonLake Immunotherapeutics (MLTX) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information